HMGB1 and cancer: Extracellular HMGB1 may induce micrometastasis via epithelial-mesenchymal transition (EMT) [24] and angiogenesis [25] by activating the receptor for advanced glycation end products/extracellular signal-regulated kinase/nuclear factor-kappa B (RAGE/Erk/NF-κB) pathway in the early stage of cancer, and it has been identified as the reason for the poor prognosis of patients with high HMGB1 expression levels.